Webinar

Next generation bioanalysis using the Gyrolab® platform. Developing biomarker and immunogenicity assays for clinical studies.

Published

Format: External webinar | Document type: Webinar

Next generation bioanalysis using the Gyrolab® platform. Developing biomarker and immunogenicity assays for clinical studies.
High throughput screening of antibody pairs to determine best binding characteristics, and their selection for development of immunoassays. Identification of instrument considerations and representative data of sensitive cytokine assays with large dynamic ranges that can be run with high throughput and low volume.

Speakers

Mark Abrams Mark Abrams Research Scientist III, BioPharma Services
EMD Millipore

Medha Kamat Medha Kamat Senior Research Scientist, BioPharma Services
EMD Millipore

Related resources from Millipore Corporation

Supplier info centre